Article ID Journal Published Year Pages File Type
6118674 International Journal of Infectious Diseases 2013 4 Pages PDF
Abstract
These results indicate that seroprotection following primary vaccination with MenACWY-TT extends more than 3 years. Ongoing persistence data are required to understand the duration of protection following vaccination and to guide decisions on the need for future booster doses.
Related Topics
Life Sciences Immunology and Microbiology Applied Microbiology and Biotechnology
Authors
, , , ,